-
Innovation Ranking
NewInnovation Ranking – Toyo Ink SC Holdings Co Ltd
Toyo Ink SC Holdings Co Ltd (Toyo Ink) is a chemical manufacturer and distributor. The company provides services such as printing and information business, a packaging business, polymer and coating business, color and functional materials business and others. Toyo Ink’s product portfolio includes printing inks, industrial chemicals, offset inks, inkjet inks, gravure inks, gravure solvents, screen inks, flexographic inks, can coatings, adhesives, pigments, high function pigments and plastic colorants, and printing equipment, and systems. The company has operations in France,...
-
Product Insights
SC Jefferson Farm Solar PV Park, US
SC Jefferson Farm Solar PV Park is located in South Carolina, United States. The power plant was commissioned in 2022. Empower your strategies with our SC Jefferson Farm Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SC-291 in Follicular Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SC-291 in Follicular Lymphoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SC-291 in Follicular Lymphoma Drug Details: SC-291 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SC-291 in Mantle Cell Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SC-291 in Mantle Cell Lymphoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SC-291 in Mantle Cell Lymphoma Drug Details: SC-291 is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SC-291 in Non-Hodgkin Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SC-291 in Non-Hodgkin Lymphoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SC-291 in Non-Hodgkin Lymphoma Drug Details: SC-291 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SC-291 in Diffuse Large B-Cell Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SC-291 in Diffuse Large B-Cell Lymphoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SC-291 in Diffuse Large B-Cell Lymphoma Drug Details: SC-291...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SC-291 in Relapsed Chronic Lymphocytic Leukemia (CLL)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SC-291 in Relapsed Chronic Lymphocytic Leukemia (CLL) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SC-291 in Relapsed Chronic Lymphocytic Leukemia (CLL) Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SC-291 in Refractory Chronic Lymphocytic Leukemia (CLL)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SC-291 in Refractory Chronic Lymphocytic Leukemia (CLL) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SC-291 in Refractory Chronic Lymphocytic Leukemia (CLL) Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SC-291 in Primary Mediastinal B-Cell Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SC-291 in Primary Mediastinal B-Cell Lymphoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SC-291 in Primary Mediastinal B-Cell Lymphoma Drug Details: SC-291...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SC-291 in Marginal Zone B-cell Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SC-291 in Marginal Zone B-cell Lymphoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SC-291 in Marginal Zone B-cell Lymphoma Drug Details: SC-291...